134 related articles for article (PubMed ID: 6429730)
21. Cancer screening services for the elderly.
Weisman CS; Celentano DD; Teitelbaum MA; Klassen AC
Public Health Rep; 1989; 104(3):209-14. PubMed ID: 2543020
[TBL] [Abstract][Full Text] [Related]
22. [Detection of colo-rectal tumors. Valve of the guaiac clinical test].
Baumel H; Giraudon M; Deizonne B; Rey MH
Med Chir Dig; 1979; 8(4):307-12. PubMed ID: 502623
[No Abstract] [Full Text] [Related]
23. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
24. The cost-effectiveness of immunochemical tests for colorectal cancer screening.
Lejeune C; Le Gleut K; Cottet V; Galimard C; Durand G; Dancourt V; Faivre J
Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177
[TBL] [Abstract][Full Text] [Related]
25. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
26. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
27. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
Trojan J; Povse N; Schröder O; Stein J
Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
[TBL] [Abstract][Full Text] [Related]
28. [Hemoccult test. Results in systematic health evaluation of the Parisian Region Central Primary Disease Insurance Desk].
Champeau J; Freche C; Jacquier L
Med Chir Dig; 1978; 7(5):423-4. PubMed ID: 723320
[No Abstract] [Full Text] [Related]
29. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
30. Screening for colorectal cancer.
Sterchi JM
South Med J; 1979 Sep; 72(9):1144-6. PubMed ID: 472841
[TBL] [Abstract][Full Text] [Related]
31. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.
Lejeune C; Dancourt V; Arveux P; Bonithon-Kopp C; Faivre J
Int J Technol Assess Health Care; 2010 Jan; 26(1):40-7. PubMed ID: 20059779
[TBL] [Abstract][Full Text] [Related]
33. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
34. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
35. The pros and cons of fecal occult blood testing for colorectal neoplasms.
Simon JB
Cancer Metastasis Rev; 1987; 6(3):397-411. PubMed ID: 3319274
[TBL] [Abstract][Full Text] [Related]
36. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
37. [Occult blood screening for colorectal cancer].
Kumanishi Y; Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2255-62. PubMed ID: 3729485
[TBL] [Abstract][Full Text] [Related]
38. Fecal occult blood tests in occult gastrointestinal bleeding.
Bond JH
Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
[TBL] [Abstract][Full Text] [Related]
39. Results of a mass screening program for colorectal cancer.
Miller MP; Stanley TV
Arch Surg; 1988 Jan; 123(1):63-5. PubMed ID: 3337658
[TBL] [Abstract][Full Text] [Related]
40. Fecal occult blood testing: clinical value and limitations.
Simon JB
Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
